Medical Device News Magazine

Artificial Intelligence May Improve Diabetes Diagnosis

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • To build the deep learning model, the researchers used a total of 471 images obtained from a variety of datasets, including the Medical Data Decathlon, The Cancer Imaging Archive and the Beyond Cranial Vault challenge.

Diabetes Diagnosis: Using a fully-automated artificial intelligence (AI) deep learning model, researchers were able to identify early signs of type 2 diabetes on abdominal CT scans, according to a new study published in the journal Radiology.

Type 2 diabetes affects approximately 13% of all U.S. adults and an additional 34.5% of adults meet the criteria for prediabetes. Due to the slow onset of symptoms, it is important to diagnose the disease in its early stages. Some cases of pre-diabetes can last up to 8 years and an earlier diagnosis will allow patients to make lifestyle changes to alter the progression of the disease.

Abdominal CT imaging can be a promising tool to diagnose type 2 diabetes. CT imaging is already widely used in clinical practices, and it can provide a significant amount of information about the pancreas. Previous studies have shown that patients with diabetes tend to accumulate more visceral fat and fat within the pancreas than non-diabetic patients. However, not much work has been done to study the liver, muscles and blood vessels around the pancreas, said study co-senior author Ronald M. Summers, M.D., Ph.D., senior investigator and staff radiologist at the National Institutes of Health Clinical Center in Bethesda, Maryland.

“The analysis of both pancreatic and extra-pancreatic features is a novel approach and has not been shown in previous work to our knowledge,” said first author Hima Tallam, B.S.E., M.D./Ph.D. student.

The manual analysis of low-dose non-contrast pancreatic CT images by a radiologist or trained specialist is a time-intensive and difficult process. To address these clinical challenges, there is a need for the improvement of automated image analysis of the pancreas, the authors said.

For this retrospective study, Dr. Summers and colleagues, in close collaboration with co-senior author Perry J. Pickhardt, M.D., professor of radiology at the University of Wisconsin School of Medicine & Public Health, used a dataset of patients who had undergone routine colorectal cancer screening with CT at the University of Wisconsin Hospital and Clinics. Of the 8,992 patients who had been screened between 2004 and 2016, 572 had been diagnosed with type 2 diabetes and 1,880 with dysglycemia, a term that refers to blood sugar levels that go too low or too high. There was no overlap between diabetes and dysglycemic diagnosis.

To build the deep learning model, the researchers used a total of 471 images obtained from a variety of datasets, including the Medical Data Decathlon, The Cancer Imaging Archive and the Beyond Cranial Vault challenge. The 471 images were then divided into three subsets: 424 for training, 8 for validation and 39 for test sets. Researchers also included data from four rounds of active learning.

The deep learning model displayed excellent results, demonstrating virtually no difference compared to manual analysis. In addition to the various pancreatic features, the model also analyzed the visceral fat, density and volumes of the surrounding abdominal muscles and organs.

The results showed that patients with diabetes had lower pancreas density and higher visceral fat amounts than patients without diabetes.

“We found that diabetes was associated with the amount of fat within the pancreas and inside the patients’ abdomens,” Dr. Summers said. “The more fat in those two locations, the more likely the patients were to have diabetes for a longer period of time.”

The best predictors of type 2 diabetes in the final model included intrapancreatic fat percentage, pancreas fractal dimension, plaque severity between the L1-L4 vertebra level, average liver CT attenuation, and BMI. The deep learning model used these predictors to accurately discern patients with and without diabetes.

“This study is a step towards the wider use of automated methods to address clinical challenges,” the authors said. “It may also inform future work investigating the reason for pancreatic changes that occur in patients with diabetes.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.